by Truveta staff | Sep 12, 2025 | Data
Non–small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases and remains the leading cause of cancer death worldwide. While major advances in targeted therapies and immunotherapies have transformed care, gaps persist in biomarker testing, treatment...
by Truveta staff | Sep 10, 2025 | Culture
At Johns Hopkins University, the Hopkins Business of Health Initiative (HBHI) has launched the HBHI–Truveta User Community, dedicated to fostering a collaborative group of researchers who use Truveta Data to drive cutting-edge research in health and healthcare. Led by...
by Truveta staff | Sep 3, 2025 | Research
Data Overview Clinical notes Images Mother-child Oncology Regulatory grade Truveta Language Model Truveta Studio Genomics Solutions Life science Public health Healthcare Research Resources About Blog Members Leadership Events & webinars Newsroom Careers Get...
by Truveta Research | Aug 1, 2025 | Research, Research Insights
62.7% of Lyme cases occurred between May and August, underscoring the heightened risk during late spring and summer. June consistently showed the highest activity, accounting for nearly 1 in 5 cases (19.4%) across observed years. Risk of Lyme remains elevated in...
by Truveta staff | May 29, 2025 | Data
Each year, more than 34,000 men in the U.S. die from prostate cancer. While early-stage disease is often highly treatable, outcomes still vary widely — especially by race, income, and geography. Catching the disease early can save lives, but real-world data on...
